For most people, a gastroenterologist is the doctor you see when something feels wrong in your digestive tract. Reflux. Bloating. Constipation. Abdominal pain. Maybe you need an endoscopy. Maybe you need a colonoscopy. Maybe you just want someone to explain why your gut has been making your life miserable.
But Dr. Michelle Pearlman’s practice evolved because she kept seeing a problem that traditional gastroenterology was not solving.
She would perform procedures, find nothing structurally wrong, and then patients would wake up and ask the most important question of all: “Then why do I still feel terrible?”
That question changed the trajectory of her career.
Because a normal scope does not always mean a normal digestive system. Endoscopies and colonoscopies are excellent for identifying structural disease, such as ulcers, tumors, inflammation, or polyps. But they do not tell you everything about motility, functional gut symptoms, dietary patterns, visceral fat, metabolic health, or the broader lifestyle factors that shape how someone feels day to day.
And that is really the heart of this conversation.
Gut health is not separate from metabolic health. Weight management is not separate from gastrointestinal health. Hormones are not separate from muscle, bone, and body composition. And medicine, if it wants to actually help people thrive, cannot keep treating these systems as if they live in different buildings.
A normal scope does not mean nothing is wrong
Dr. Pearlman trained as a gastroenterologist because she assumed it would be the branch of medicine most deeply connected to nutrition. After all, the gastrointestinal tract is where food enters the body, where digestion happens, where nutrients are absorbed, and where the gut microbiome interacts with the immune system.
Instead, she says, her training focused largely on pathology.
She learned about celiac disease, inflammatory bowel disease, reflux disease, fatty liver, and other clear medical diagnoses. What she did not learn in depth was nutrition. She did not learn how to work through a patient’s eating habits, meal timing, food quality, body composition, or the metabolic drivers that may be worsening their symptoms.
That gap matters more than most doctors care to admit. Take reflux, for example. Many patients with heartburn or acid reflux are placed on proton pump inhibitors or other antacids. These medications can be very useful, and Dr. Pearlman still uses them when appropriate, but they do not always address the underlying reason the reflux is happening.
If someone has significant visceral fat around the abdomen, that extra mass can increase pressure inside the abdominal cavity. In practical terms, it can act like an external corset squeezing the stomach. That pressure makes it easier for stomach contents to move upward into the esophagus. An antacid may reduce the burning sensation, but it does not remove the mechanical driver.
The same is true for the daily habits that often make reflux worse. Eating a large meal late at night. Eating quickly. Taking in a lot of fluid with meals. Lying down shortly after eating. Choosing very fatty meals in the evening. These behaviors matter even off medication, and they can matter even more for people taking GLP-1 drugs, which slow gastric emptying.
This is why Dr. Pearlman’s approach feels so different from the typical quick-fix model. She is not anti-medication. She is anti-stopping at medication when the deeper problem is still sitting there untouched.
That distinction also comes up with over-the-counter drugs. People often assume that if something is available without a prescription, it must be harmless. But as she points out, gastroenterologists regularly see the consequences of excessive NSAID use, such as ibuprofen-related ulcers and gastrointestinal bleeding. Over-the-counter does not mean risk-free.
And while nuance matters, there is one place where Dr. Pearlman is willing to be very direct: do not ignore warning signs.
Rectal bleeding, even if it only appears when wiping, should not automatically be dismissed as hemorrhoids. Persistent or worsening abdominal pain matters. Unintentional weight loss matters. Ongoing nausea or vomiting matters. These symptoms deserve evaluation, especially in a world where colorectal cancer is appearing at younger ages than it once did.
Screening colonoscopy now begins at age 45 for average-risk adults, but symptoms are not bound by screening age. A 25-year-old with rectal bleeding is not “too young” to be taken seriously. That old assumption has already failed too many people.
The broader message is simple: the absence of a dramatic finding on a scope does not mean a patient is imagining their symptoms. It may mean we need to widen the lens.
GLP-1s are changing medicine, but not if we use them carelessly
A major part of this episode centers on GLP-1 medications, and Dr. Pearlman brings an especially valuable perspective because she works at the intersection of gastroenterology, weight management, and metabolic medicine.
One of the first myths she pushes back on is the idea that these drugs appeared out of nowhere. GLP-1-based medications have existed for roughly two decades, initially as treatments for type 2 diabetes. What changed over time was their effectiveness, their dosing, and their application to obesity treatment.
Earlier medications such as liraglutide produced modest weight loss. Newer agents such as semaglutide and tirzepatide are far more powerful. Some upcoming medications may rival bariatric surgery-level weight loss. Dr. Pearlman refers to the field as moving beyond “weight loss drugs” toward what one specialist called metabolic reprogrammers.
These medications do more than simply blunt appetite. They slow gastric emptying, help people feel full sooner and longer, improve blood sugar regulation, and influence brain pathways involved in cravings, reward, and food noise. Dr. Pearlman emphasizes that her goal is not to eliminate hunger entirely. Hunger is a normal biological signal. Her goal is to help people eat a meal, feel satisfied, and no longer spend the next several hours mentally battling relentless thoughts about food.
And yet, despite the medical legitimacy of these drugs, patients often feel ashamed to use them. Dr. Pearlman says many of her patients will openly tell friends they are using hormone therapy, but stay quiet about GLP-1s. The stigma is that needing help with weight loss reflects personal failure. That somehow if you could not achieve and sustain fat loss through sheer willpower, you have taken the easy way out.
No one accuses a patient of cheating because they use blood pressure medication. No one says insulin is a moral shortcut. But once body weight enters the conversation, people suddenly treat biology like a character test.
At the same time, Dr. Pearlman is not arguing that these medications should be handed out casually. In fact, one of her biggest concerns is exactly the opposite. She worries that healthcare is sliding from weight management into what she calls “weight loss commerce.”
The prescription itself is easy. The hard part is the care around it.
When someone undergoes bariatric surgery, there is typically a full system around them: nutritional guidance, psychological assessment, follow-up visits, postoperative monitoring, and long-term support. With GLP-1s, a patient may be prescribed medication online, receive minimal education, and be told to check back months later. That is not enough.
These medications can be extraordinarily useful. But as they become more potent, the risk of doing weight loss poorly also rises. Someone can lose a substantial amount of weight while undereating protein, failing to resistance train, losing meaningful lean tissue, becoming constipated, worsening reflux, and drifting into nutrient deficiencies.
The drugs are not dangerous by themselves. The danger is powerful medication without adequate guidance.
The new problem is not just obesity. It is undernourished weight loss
For years, modern medicine has been dealing with people who are overfed but undernourished. Now, Dr. Pearlman worries we may see more people who are underfed and still undernourished, especially when GLP-1s are used without a structured nutrition plan.
That concern shows up in her conversations about protein, fiber, micronutrients, hair loss, bowel function, and supplementation.
When appetite falls, food volume often falls with it. That can be helpful for fat loss, of course. But it can also mean people eat less protein, less fiber, and fewer micronutrient-dense foods unless they are being intentional. Dr. Pearlman often encourages patients to work toward at least 100 to 120 grams of protein per day, though she is careful to meet them where they are. If someone is starting from 40 grams, jumping immediately to 150 is not realistic. The target has to progress step by step.
She also pays attention to nutritional labs. Many people with overweight or obesity are already micronutrient deficient before they ever start medication. B12, vitamin D, iron status, and other markers may be relevant, especially if overall food intake decreases further.
Hair loss is one issue she sees clinically. It is likely multifactorial. Many of her patients are also perimenopausal. Rapid weight loss itself can contribute. Lower protein intake can contribute. Iron status may contribute. The answer is not to throw a random “hair supplement” at the problem and hope for the best. It is to ask what changed, what is missing, and what needs to be corrected.
Her supplement philosophy is refreshingly restrained. Food comes first. Supplements are useful when they solve a specific problem. Creatine is one she strongly favors, especially in patients who are resistance training. She is open to collagen when patients find it helpful for hair, skin, or nails. She uses targeted B12, iron, or vitamin D support when needed. But she is skeptical of all-in-one formulas that toss the entire supplement aisle into one capsule, especially when the ingredients may interfere with one another’s absorption.
Fiber is another major pillar. Dr. Pearlman recommends aiming for roughly 25 to 35 grams per day for many people, especially those who are constipated or struggling with a low-fiber diet. Fiber feeds gut microbes. Those microbes, in turn, produce compounds such as short-chain fatty acids that help support the health of the colon and may influence broader metabolic and immune function.
But more is not always better. She sees people go from very low fiber intake to highly fortified “diet foods” loaded with synthetic fiber and then wonder why they are bloated and miserable. The gut often needs time to adapt. Whole-food sources tend to provide a more balanced matrix of soluble and insoluble fibers than aggressively engineered fiber products.
Constipation deserves special attention, particularly for people using GLP-1 medications. Dr. Pearlman notes that dehydration, lower food intake, lower fiber intake, and the medications’ effects on motility can all contribute. Sometimes an osmotic laxative such as polyethylene glycol helps. Sometimes stimulant laxatives are appropriate. Sometimes suppositories or enemas are useful in specific cases.
But sometimes the problem is not the colon. It is the pelvic floor. If someone feels like stool is there but they cannot evacuate it effectively, they may have pelvic floor dysfunction. No amount of fiber stacking will fix a coordination problem in the muscles involved in elimination. Those patients may need pelvic floor physical therapy rather than yet another bowel supplement.
That is a perfect example of the kind of care Dr. Pearlman is advocating for. Not reflexive protocols. Not generic handouts. Actual problem-solving.
Weight loss is not the finish line. Strength, muscle, and bone are
One of the most important parts of this conversation is the shift from weight loss to what happens after weight loss. It is not enough to get smaller. The goal is to become healthier, stronger, more capable, and more resilient.
Dr. Pearlman is clear that some lean tissue loss happens across essentially all substantial weight-loss strategies, whether through dieting, GLP-1 medications, or bariatric surgery. The important question is not simply whether lean mass drops on a scan. The more meaningful question is: what happens to strength, physical function, and long-term frailty risk?
A patient may lose weight and show some reduction in lean tissue, yet feel stronger, move better, and perform better than before. That matters. Dr. Pearlman argues that clinical medicine is missing a major opportunity by failing to track simple functional metrics such as handgrip strength, sit-to-stand ability, gait-related testing, or other measures of physical capability.
We measure blood pressure at every routine visit. We record body weight. But strength, one of the most powerful indicators of how well someone may age, is often invisible in the medical chart. That needs to change.
In her clinic, Dr. Pearlman tracks body composition trends over time, but she uses them as conversation starters, not as the entire verdict. If someone loses two pounds of lean tissue in a month, that prompts questions. How much protein are they actually eating? Are they guessing portion sizes? Are they resistance training? Is their program built to stimulate muscle growth, or are they just doing nonstop circuit classes with no progressive overload and no real rest between sets?
This is another major point in the episode: not all exercise is equally effective for building or preserving muscle. People may be working hard, sweating hard, and still not providing the body with the signal required to build meaningful muscle. Muscle requires progressive tension, adequate recovery, and adequate fuel. Endless moderate-intensity classes may have value, but they are not automatically a muscle-building program.
Hormones also enter the conversation here, especially for women in midlife.
Dr. Pearlman is careful to say that hormone therapy is not a weight-loss strategy. Giving estrogen, progesterone, or testosterone does not automatically make body fat disappear. But hormones can profoundly affect sleep, hot flashes, night sweats, libido, bone health, cognition, and quality of life. And those factors can indirectly shape someone’s ability to train, recover, and maintain a healthy body composition.
She also shares something she has observed clinically: some of her most successful female patients are those combining a thoughtful weight-loss strategy, resistance training, adequate nutrition, and appropriate hormone therapy when indicated. In her practice, she has seen lean tissue losses begin to stabilize and muscle gain become more achievable once that broader physiology is being addressed.
This is especially personal for her because she has lived through a wake-up call of her own. Despite years of bodybuilding, heavy lifting, high protein intake, and an outwardly fit appearance, Dr. Pearlman learned at age 39 that she had osteoporosis of the lumbar spine and osteopenia at the hip. She was stunned. She had done so many of the things people are told to do. But looking back, she also recognized years of under-fueling, overtraining, missed menstrual cycles, and treating those warning signs as proof of discipline rather than as evidence that her physiology was under strain.
That story changes the emotional weight of this conversation because when she talks about bone health, muscle health, and prevention, she is not speaking abstractly. She is talking about a future that can be altered if people are informed early enough. She wants women to understand that osteopenia and osteoporosis do not suddenly become relevant at age 65. The groundwork is laid much earlier, during the years when bone and muscle are still easier to build and protect.
Yet, medicine is often reactive. We wait for the fracture. We wait for diabetes. We wait for severe reflux. We wait for the colonoscopy finding. We wait for the visible decline. Then we act as if prevention was never available.
Dr. Pearlman’s approach is different. She wants better education. Better tracking. Better integration of nutrition, body composition, strength, hormonal health, and real-world symptoms. She also believes technology can help fill the care gap, especially in a system where most physicians have nowhere near enough time to conduct the kind of deep, nuanced counseling people actually need.
The future of medicine may include more medications. More data. More wearable tracking. More personalized nutrition platforms. But the foundation will remain surprisingly familiar:
Eat well. Build muscle. Maintain bone. Protect your gut. Pay attention to symptoms. Use medications wisely. And do not confuse a prescription with a complete plan.
Action checklist
Do not dismiss persistent gut symptoms just because a scope is normal. Functional symptoms, motility issues, eating habits, and metabolic drivers may still be involved.
Pay attention to reflux triggers. Large late meals, high-fat dinners, eating quickly, lying down after eating, and excess abdominal pressure can all matter.
Never ignore warning signs. Rectal bleeding, unintentional weight loss, persistent abdominal pain, ongoing vomiting, or worsening symptoms deserve medical evaluation.
Treat GLP-1s like powerful medical tools, not casual lifestyle products. The prescription is the easy part. The plan around it is what protects long-term outcomes.
Prioritize protein and resistance training during weight loss. The goal is not simply to weigh less. It is to lose fat while preserving or rebuilding strength and function.
Increase fiber thoughtfully. Aim for more whole-food fiber over time, not a sudden flood of engineered high-fiber products that leave you bloated and miserable.
Hydration matters, especially on GLP-1s. Appetite suppression, lower intake, and gastrointestinal side effects can all increase the risk of dehydration.
If constipation persists, think beyond “just eat more fiber.” Pelvic floor dysfunction is real and may require specialized physical therapy.
Use supplements strategically. Correct what is low or clinically relevant rather than relying on “everything in one” products.
For women in midlife, do not reduce every concern to body weight. Sleep, hormones, bone density, lean tissue, and quality of life all deserve attention.
Track function, not just the scale. Strength, movement capacity, and real-world physical performance are more meaningful than a single body-weight number.
Start the muscle and bone conversation early. Waiting until frailty, osteoporosis, or fracture risk is obvious means the most valuable prevention window may already be shrinking.
